Terms: = Germ cell tumor AND REL, I-Rel, 5966, ENSG00000162924, C-Rel
64 results:
1. Classification of brain lesions using a machine learning approach with cross-sectional ADC value dynamics.
Solar P; Valekova H; Marcon P; Mikulka J; Barak M; Hendrych M; Stransky M; Siruckova K; Kostial M; Holikova K; Brychta J; Jancalek R
Sci Rep; 2023 Jul; 13(1):11459. PubMed ID: 37454179
[TBL] [Abstract] [Full Text] [Related]
2. Outcomes of relapsed/refractory extracranial germ cell tumors treated on conventional salvage chemotherapy without stem cell rescue: Experience from a tertiary cancer center.
Ramanathan S; Prasad M; Vora T; Badira CP; Kembhavi S; Ramadwar M; Khanna N; Laskar S; Muckaden MA; Qureshi S; Banavali S; Chinnaswamy G
Pediatr Blood Cancer; 2023 Apr; 70(4):e30179. PubMed ID: 36645132
[TBL] [Abstract] [Full Text] [Related]
3. Novel treatment strategy of targeting epigenetic dysregulation in pancreatic neuroendocrine tumors.
Zhu C; Sandilos G; Williamson J; Emery R; Platoff R; Joneja U; Acharya NK; Lin A; Badach J; Zilberman B; Madzo J; Jelinek J; Zhang P; Hong YK
Surgery; 2023 Apr; 173(4):1045-1051. PubMed ID: 36642656
[TBL] [Abstract] [Full Text] [Related]
4. Targeting Key Signaling Pathways in Glioblastoma Stem cells for the Development of Efficient Chemo- and Immunotherapy.
Helweg LP; Storm J; Witte KE; Schulten W; Wrachtrup L; Janotte T; Kitke A; Greiner JFW; Knabbe C; Kaltschmidt B; Simon M; Kaltschmidt C
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361720
[TBL] [Abstract] [Full Text] [Related]
5. Genomic analysis of paired IDHwt glioblastomas reveals recurrent alterations of MPDZ at relapse after radiotherapy and chemotherapy.
Chanez B; Appay R; Guille A; Lagarde A; Colin C; Adelaide J; Denicolai E; Jiguet-Jiglaire C; Bequet C; Graillon T; Boissonneau S; Nanni-Metellus I; Dufour H; Figarella-Branger D; Chinot O; Tabouret E
J Neurol Sci; 2022 May; 436():120207. PubMed ID: 35259554
[TBL] [Abstract] [Full Text] [Related]
6.
Tabasaran J; Schuhmann M; Ebinger M; Honegger J; Renovanz M; Schittenhelm J
J Clin Pathol; 2022 Nov; 75(11):759-765. PubMed ID: 34183436
[TBL] [Abstract] [Full Text] [Related]
7. NF-κB c-rel Is Dispensable for the Development but Is Required for the Cytotoxic Function of NK cells.
Vicioso Y; Wong DP; Roy NK; Das N; Zhang K; Ramakrishnan P; Parameswaran R
Front Immunol; 2021; 12():652786. PubMed ID: 33995369
[TBL] [Abstract] [Full Text] [Related]
8. Cannabidiol converts NF-κB into a tumor suppressor in glioblastoma with defined antioxidative properties.
Volmar MNM; Cheng J; Alenezi H; Richter S; Haug A; Hassan Z; Goldberg M; Li Y; Hou M; Herold-Mende C; Maire CL; Lamszus K; Flüh C; Held-Feindt J; Gargiulo G; Topping GJ; Schilling F; Saur D; Schneider G; Synowitz M; Schick JA; Kälin RE; Glass R
Neuro Oncol; 2021 Nov; 23(11):1898-1910. PubMed ID: 33864076
[TBL] [Abstract] [Full Text] [Related]
9. Quantitating Interfraction Target Dynamics During Concurrent Chemoradiation for Glioblastoma: A Prospective Serial Imaging Study.
Stewart J; Sahgal A; Lee Y; Soliman H; Tseng CL; Detsky J; Husain Z; Ho L; Das S; Maralani PJ; Lipsman N; Stanisz G; Perry J; Chen H; Atenafu EG; Campbell M; Lau AZ; Ruschin M; Myrehaug S
Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):736-746. PubMed ID: 33068687
[TBL] [Abstract] [Full Text] [Related]
10. NF-кB inhibition by DHMEQ: in vitro antiproliferative effects on pilocytic astrocytoma and concise review of the current literature.
Candido MF; Baldissera GC; Medeiros M; Umezawa K; Brassesco MS
Childs Nerv Syst; 2020 Nov; 36(11):2675-2684. PubMed ID: 32385563
[TBL] [Abstract] [Full Text] [Related]
11. Constitutive expression of c-rel in uveal melanoma patients: correlation with clinicopathological parameters and patient outcome.
Singh MK; Singh L; Pushker N; Chosdol K; Bakhshi S; Meel R; Sen S; Kashyap S
Clin Transl Oncol; 2020 Jul; 22(7):1193-1204. PubMed ID: 31768922
[TBL] [Abstract] [Full Text] [Related]
12. Neuroprotective effects of glucomoringin-isothiocyanate against H
Jaafaru MS; Nordin N; Rosli R; Shaari K; Bako HY; Saad N; Noor NM; Abdull Razis AF
Neurotoxicology; 2019 Dec; 75():89-104. PubMed ID: 31521693
[TBL] [Abstract] [Full Text] [Related]
13. Identification of canonical NFκB (C-NFκB) pathway in uveal melanoma and their relation with patient outcome.
Singh MK; Singh L; Pushker N; Saini N; Meel R; Chosdol K; Bakhshi S; Sen S; Venkatesh P; Chawla B; Kaur J; Kashyap S
Clin Exp Metastasis; 2019 Jun; 36(3):271-290. PubMed ID: 31069565
[TBL] [Abstract] [Full Text] [Related]
14. Molecular grouping and outcomes of young children with newly diagnosed ependymoma treated on the multi-institutional SJYC07 trial.
Upadhyaya SA; Robinson GW; Onar-Thomas A; Orr BA; Billups CA; Bowers DC; Bendel AE; Hassall T; Crawford JR; Partap S; Fisher PG; Tatevossian RG; Seah T; Qaddoumi IA; Vinitsky A; Armstrong GT; Sabin ND; Tinkle CL; Klimo P; Indelicato DJ; Boop FA; Merchant TE; Ellison DW; Gajjar A
Neuro Oncol; 2019 Oct; 21(10):1319-1330. PubMed ID: 30976811
[TBL] [Abstract] [Full Text] [Related]
15. c-rel is a cell cycle modulator in human melanoma cells.
Priebe MK; Dewert N; Amschler K; Erpenbeck L; Heinzerling L; Schön MP; Seitz CS; Lorenz VN
Exp Dermatol; 2019 Feb; 28(2):121-128. PubMed ID: 30466153
[TBL] [Abstract] [Full Text] [Related]
16. Craniospinal irradiation as part of re-irradiation for children with recurrent intracranial ependymoma.
Tsang DS; Murray L; Ramaswamy V; Zapotocky M; Tabori U; Bartels U; Huang A; Dirks PB; Taylor MD; Hawkins C; Bouffet E; Laperriere N
Neuro Oncol; 2019 Mar; 21(4):547-557. PubMed ID: 30452715
[TBL] [Abstract] [Full Text] [Related]
17. Quality-adjusted survival of nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone among treatment-naive patients with advanced melanoma: a quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis.
McDermott DF; Shah R; Gupte-Singh K; Sabater J; Luo L; Botteman M; Rao S; Regan MM; Atkins M
Qual Life Res; 2019 Jan; 28(1):109-119. PubMed ID: 30191365
[TBL] [Abstract] [Full Text] [Related]
18. Epithelial-to-mesenchymal transition-related transcription factors are up-regulated in ependymomas and correlate with a poor prognosis.
Malgulwar PB; Nambirajan A; Pathak P; Rajeshwari M; Suri V; Sarkar C; Singh M; Sharma MC
Hum Pathol; 2018 Dec; 82():149-157. PubMed ID: 30067950
[TBL] [Abstract] [Full Text] [Related]
19. MRI Phenotype of relA-fused Pediatric Supratentorial Ependymoma.
Nowak J; Jünger ST; Huflage H; Seidel C; Hohm A; Vandergrift LA; von Hoff K; Rutkowski S; Pietsch T; Warmuth-Metz M
Clin Neuroradiol; 2019 Dec; 29(4):595-604. PubMed ID: 30027327
[TBL] [Abstract] [Full Text] [Related]
20. NF-κB upregulation through epigenetic silencing of LDOC1 drives tumor biology and specific immunophenotype in Group A ependymoma.
Griesinger AM; Witt DA; Grob ST; Georgio Westover SR; Donson AM; Sanford B; Mulcahy Levy JM; Wong R; Moreira DC; DeSisto JA; Balakrishnan I; Hoffman LM; Handler MH; Jones KL; Vibhakar R; Venkataraman S; Foreman NK
Neuro Oncol; 2017 Oct; 19(10):1350-1360. PubMed ID: 28510691
[TBL] [Abstract] [Full Text] [Related]
[Next]
